FDA Consulting & U.S. Agent Services
Accurate navigation of U.S. FDA requirements requires a clear understanding of how regulatory obligations apply to a company’s role, product portfolio, and market entry pathway. U.S. FDA Consulting encompasses the regulatory, registration, and compliance activities required to legally manufacture, list, distribute, or relabel medical devices in the United States, while also guiding companies through appropriate FDA regulatory pathways, including 510(k), De Novo, PMA, IDE, and Q-Submission processes, to support clearance, approval, and early regulatory engagement.
At Materials Metric, we deliver end-to-end U.S. FDA consulting and Registered U.S. FDA Agent services that integrate establishment registration, device listing, U.S. Agent representation, FDA pathway strategy, and quality and compliance support under 21 CFR Part 820. We manage FDA submissions through FURLS, support QMS development and maintenance, and assist with pre-submission interactions, clearance and approval planning, and post-market compliance. This integrated approach enables domestic and international manufacturers, specification developers, distributors, and relabelers to reduce regulatory risk, streamline FDA interactions, and sustain long-term U.S. market readiness.
FDA Consulting, Pathways & Execution
Materials Metric supports regulatory decision-making and execution across the full FDA lifecycle, from early pathway selection through clearance, approval, and post-market readiness.
• Determine correct FDA regulatory pathway and business role
• Prepare Q-Submission questions and FDA meeting content
• Define regulatory strategy for manufacturers, distributors, and specification developers
• Develop FDA-ready testing and data strategies
• Support 510(k), De Novo, PMA, and IDE submissions
• Address regulatory questions, deficiencies, and data gaps
• Serve as Registered U.S. FDA Agent and manage FDA correspondence
FDA consulting and U.S. Agent Services: Products, Roles & Market Entry Scenarios
Our FDA consulting and U.S. Agent services support a wide range of device types and regulatory roles.
• Class I, II, and III medical devices
• Biomaterials, coatings, and surface-engineered products
• Diagnostic and analytical platforms
• Implantable and combination products
• Foreign manufacturers entering the U.S. market
• Distributors, relabelers, and specification developers
• Companies requiring FDA establishment registration and device listing
FDA Consulting Process: From Pathway to Compliance
Our consulting process integrates regulatory strategy, registration execution, and compliance support into a single, coordinated workflow.
1. Regulatory Pathway & Registration Definition
• FDA pathway determination (510(k), De Novo, PMA, IDE)
• Predicate identification and justification
• Establishment registration and FURLS setup
• Device classification and listing strategy
• U.S. FDA Agent designation and representation
2. Testing & Compliance Strategy Development
• Performance and verification testing strategy
• Biocompatibility and chemical safety planning
• Sterilization, packaging, and shelf-life requirements
• Quality system alignment with 21 CFR Part 820
• Compliance gap assessments
3. Submission, Interaction & Ongoing Support
• Technical documentation and submission support
• Scientific rationales and regulatory argumentation
• Q-Submission preparation and FDA interaction support
• FDA correspondence, inquiries, and inspection coordination
• Post-market compliance, renewals, and listing maintenance
Why Choose Materials Metric
Materials Metric combines deep scientific rigor with practical regulatory execution to support successful FDA market entry and long-term compliance. Unlike firms that offer advisory-only guidance, we deliver hands-on regulatory support and serve as a Registered U.S. FDA Agent, enabling direct, efficient interaction with the FDA throughout the product lifecycle.
We offer
• Registered U.S. FDA Agent services for foreign manufacturers
• ISO 9001:2015–aligned documentation and quality practices
• Cross-disciplinary expertise spanning medical devices, biomaterials, and life sciences
• FDA-recognized testing and regulatory strategies across 510(k), De Novo, PMA, and IDE pathways
• Strong scientific and technical justification to support claims and submissions
• Structured, efficient guidance for FDA registration, listing, submissions, and inspections
We help ensure your FDA activities are accurate, defensible, and aligned with FDA expectations—reducing regulatory risk while accelerating time to market.
Related services